Business Context and Reporting Period
Company: Silicon Valley Acquisition Corp. (SVAQ)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025 (Inception: July 21, 2025)
Business Overview: The Company is a Cayman Islands exempted company and a Special Purpose Acquisition Company (SPAC) formed to effect a merger, share exchange, or asset acquisition with one or more target businesses. The Company has no operating history and has generated no operating revenues to date. It focuses on sectors including fintech, crypto/digital assets, AI-driven infrastructure, energy transition, and technology.
Capitalization Status: The Company consummated its Initial Public Offering (IPO) on December 24, 2025, selling 20,000,000 units. On January 7, 2026, the underwriters partially exercised the over-allotment option, purchasing an additional 1,500,000 units. The remaining over-allotment option expired on February 7, 2026.
Key Financial Metrics
| Metric | Value |
|---|---|
| Net Loss (Inception to Dec 31, 2025) | $(343,073) |
| Operating Expenses | $486,154 (Includes $346,500 share-based compensation) |
| Other Income | $143,081 (Interest income and unrealized gains) |
| Cash and Cash Equivalents (Outside Trust) | $1,600,031 |
| Investments Held in Trust Account | $200,119,181 |
| Total Assets | $201,879,569 |
| Total Liabilities | $8,316,797 |
| Deferred Underwriting Fees | $8,000,000 (Base) + $600,000 (Over-allotment) |
| Working Capital | $1,370,746 |
Material Changes and Capital Structure
- Trust Account Balance: Following the IPO and partial over-allotment exercise, approximately $221,550,000 was placed in the Trust Account. As of December 31, 2025, the balance was $200,119,181, reflecting interest earned on the initial $200,000,000 deposit. The subsequent over-allotment proceeds were deposited in January 2026.
- Share Structure:
- Class A Ordinary Shares: 20,000,000 shares subject to possible redemption (temporary equity) and 625,000 private placement shares.
- Class B Ordinary Shares (Founder Shares): 7,165,950 shares issued and outstanding as of the filing date. 499,950 shares were forfeited following the expiration of the unexercised portion of the over-allotment option.
- Warrants: 10,000,000 public warrants and 312,500 private placement warrants outstanding. Exercise price is $11.50 per share.
Guidance, Outlook, and Risks
Outlook and Timeline: The Company has 24 months from the closing of the IPO (December 24, 2025) to complete an initial business combination, with a deadline of December 24, 2027. If no combination is completed by this date, the Company will liquidate and redeem public shares pro rata from the Trust Account.
Management Commentary: Management intends to use funds from the Trust Account, equity, or debt to complete a business combination. They have not identified a specific target. The Company is classified as an "emerging growth company" and a "smaller reporting company."
Key Risks and Contingencies:
- Liquidity: The Company relies on the Trust Account for the business combination and working capital outside the Trust for operations. If operating funds are insufficient, the Sponsor may provide loans, though they are not obligated to do so.
- Redemption Risk: Public shareholders may redeem shares for cash upon a business combination, which could reduce the cash available for the transaction.
- Regulatory: The Company is subject to new SEC rules for SPACs (2024 SPAC Rules) which impose additional disclosure and financial statement requirements.
- Investment Company Act: There is a risk the Company could be deemed an investment company if it holds securities in the Trust Account for too long, though it intends to liquidate securities into cash to mitigate this.
Investor Verification Checklist
- Trust Account Composition: Verify the current balance and composition of the Trust Account, specifically noting the impact of the January 2026 over-allotment proceeds which occurred after the balance sheet date.
- Share Forfeiture: Confirm the final count of Class B Founder Shares following the expiration of the over-allotment option (499,950 shares were forfeited).
- Deferred Fees: Note the total deferred underwriting commission liability of $8,600,000, payable only upon completion of a business combination.
- Related Party Transactions: Review the $25,000 monthly administrative fee paid to the Sponsor and the potential for working capital loans from the Sponsor or affiliates.
- Warrant Terms: Verify the exercise price ($11.50) and the redemption trigger price ($18.00) for public warrants.